Clinical Trials Directory

Trials / Completed

CompletedNCT06073223

Intervention to Decrease Overtreatment of Patients With Low-risk Thyroid Cancer

Pilot Study of an Intervention to Decrease Overtreatment of Patients With Low-risk Thyroid Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
University of Michigan Rogel Cancer Center · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The study will include 50 patients newly diagnosed with low-risk thyroid cancer ranging from 18-80 years of age. After scheduling their surgeon visit, the investigators will enroll patients and measure their intended treatment choice, baseline awareness of the three treatment options, expected outcomes, self-efficacy, and activation. The participants will then be randomized 1:1 and deliver the CQUPLE intervention to the intervention group. The control group will receive usual care, which involves providing no disease or treatment specific information outside the surgeon visit. The study team will repeat all measures prior to the surgical consult and after the surgical consult. The study team will record the patients' actual treatment choice after the consult.

Conditions

Interventions

TypeNameDescription
OTHERUsual CareThe control group will receive usual care, which involves providing no disease or treatment specific information outside the surgeon visit.
OTHERCQUPLEOur research team developed a novel intervention called CQUPLE (pronounced "couple"), which includes two interventions delivered together: (1) a Chart of side-by-side, evidence-based information comparing all three treatment options for low-risk thyroid cancer, including expected outcomes and (2) a Question Prompt List that contains key questions to consider asking the surgeon. The intervention is grounded in social cognitive theory and aims to increase patient awareness of treatment options and their outcomes, patient activation, and self-efficacy for decision making.

Timeline

Start date
2023-09-18
Primary completion
2025-12-20
Completion
2025-12-20
First posted
2023-10-10
Last updated
2026-02-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06073223. Inclusion in this directory is not an endorsement.